The Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

John T. Kissel

doi:10.1055/s-2003-41130

Seminars in Neurology, Table of Contents

Semin Neurol 2003; 23(2): 169-180
DOI: 10.1055/s-2003-41130

The Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

John T. Kissel

Department of Neurology, Division of Neuromuscular Disease, The Ohio State University, Columbus, Ohio

Abstract

ABSTRACT

Chronic inflammatory demyelinating polyradiculoneuropathy is an inflammatory disorder of nerve that usually presents with slowly progressive weakness and sensory loss and areflexia. It is among the most treatable of the peripheral nerve disorders, and several modalities have been shown to be effective in prospective, randomized controlled trials. Although most patients show a gratifying early response to treatment, in many cases the patients relapse. The cumulative effects of the neuropathic impairments, along with side effects from long-term immunosuppressive treatment, combine to produce significant long-term morbidity and loss of function. This review will cover the epidemiology, clinical features, laboratory findings, and pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy; the current status of the treatment of this disorder will be reviewed, highlighting those therapies shown to be effective in randomized controlled trials.

KEYWORDS

Neuropathy - polyradiculoneuropathy - intravenous immunoglobulin - plasma exchange - corticosteroids - inflammatory neuropathy - prednisone

Full Text

References

REFERENCES

1 Lunn M PT, Manji H, Choudhary P P. et al . Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry . 1999; 66 269-271
2 McLeod J G, Pollard J D, Macaskill P. et al . Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol . 1999; 46 910-913
3 Hughes R AC. Chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol . 2001; 50 281-282
4 Dyck P J, Oviatt K F, Lambert E H. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol . 1981; 10 222-226
5 Barohn R J. Approach to peripheral neuropathy and neuronopathy. Sem Neurol . 1998; 18 7-18
6 McCombe P A, Pollard J D, McLeod J G. Chronic inflammatory demyelinating polyradiculoneuropathy: a clinical and electrophysiological study of 92 cases. Brain . 1987; 110 1617-1630
7 Barohn R J, Kissel J T, Warmolts J R, Mendell J R. Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol . 1989; 46 878-884
8 Barbieri F, De Michele G, Santoro L, Santangelo R, Ragno M. Chronic inflammatory demyelinating polyradiculoneuropathy: a clinical, electrophysiological and biopsy study. Clin Neurol Neurosurg . 1991; 93 99-106
9 Bromberg M B, Feldman E L, Albers J W. Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy. Neurology . 1992; 42 1157-1163
10 Nevo Y, Pestronk A, Kornberg A J. et al . Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up. Neurology . 1996; 47 98-102
11 Maisonobe T, Chassande B, Verin M, Jouni M, Leger J M, Bouche P. Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients. J Neurol Neurosurg Psych . 1996; 61 36-42
12 Gorson K C, Allam G, Ropper A H. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology . 1997; 48 321-328
13 Bouchard C, Lacroix C, Plante V. et al . Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology . 1999; 52 498-503
14 Sghirlanzoni A, Solari A, Ciano C, Mariotti C, Fallica E, Pareyson D. Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. Neurol Sci . 2000; 21 31-37
15 Bosboom W M, van den Berg H L, Fransssen H. et al . Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain . 2001; 124 2427-2438
16 Simmons Z, Wald J J, Albers J W. Chronic inflammatory demyelinating polyradiculoneuropathy in children I: presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults. Muscle Nerve . 1997; 20 1008-1015
17 Hattori N, Ichimura M, Aoki S. et al . Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood. J Neurol Sci . 1998; 154 66-71
18 Ryan M M, Grattan-Smith P J, Procopis P G, Morgan G, Ouvrier R A. Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and long-term outcome. Neuromuscul Disord . 2000; 10 398-406
19 Nevo Y, Topaloglu H. 88th ENMC international workshop: childhood chronic inflammatory demyelinating polyneuropathy (including revised diagnostic criteria). Neuromuscul Disord . 2002; 12 195-200
20 Connolly A M. Chronic inflammatory demyelinating polyneuropathy in childhood. Ped Neurology . 2001; 24 177-182
21 Mori K, Hattori N, Sugiura M. et al . Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS. Neurology . 2002; 58 979-982
22 Waddy H M, Misra V P, King R H, Thomas P K, Middleton L, Ormerod I E. Focal cranial nerve involvement in chronic inflammatory demyelinating polyneuropathy: clinical and MRI evidence of peripheral and central lesions. J Neurol . 1989; 236 400-405
23 McCann E L, Smith T W, Chad D A, Sargent J. Severe cranial nerve involvement in longstanding demyelinating polyneuropathy: a clinicopathologic correlation. Acta Neuropath . 1996; 91 309-312
24 Midroni G, Dyck P J. Chronic inflammatory demyelinating polyradiculoneuropathy: unusual clinical features and therapeutic responses. Neurology . 1996; 46 1206-1212
25 Dalakas M C. Advances in chronic inflammatory demyelinating polyneuropathy: disease variants and inflammatory response mediators and modifiers. Curr Opin Neurol . 1999; 12 403-409
26 Saperstein D S, Katz J S, Amato A A, Barohn R J. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve . 2001; 24 311-324
27 Kuwabara S, Ogawara K, Misawa S, Mori M, Hattori T. Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry . 2002; 72 37-42
28 Hausmanowa-Petrusewicz I, Rowinska-Marcinska K, Kopec A. Chronic acquired demyelinating motor neuropathy. Acta Neurol Scand . 1991; 84 40-45
29 Donaghy M, Mills K R, Boniface S J. et al . Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psych . 1994; 57 778-783
30 Sabatelli M, Madia F, Mignogna T, Lippi G, Quaranta L, Tonali P. Pure motor chronic inflammatory demyelinating polyneuropathy. J Neurol . 2001; 248 772-777
31 Oh S J, Joy J L, Kuruoglu R. "Chronic sensory demyelinating neuropathy": chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy. J Neurol Neurosurg Psychiatry . 1992; 55 677-680
32 van Dijk W G, Notermans N C, Franssen H, Wokke J H. Development of weakness in patients with chronic inflammatory demyelinating polyneuropathy and only sensory symptoms at presentation: a long-term follow-up study. J Neurol . 1999; 246 1134-1139
33 Ohkoshi N, Harada K, Magata H, Yato M, Shoji S. Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy: clinical features and pathological study of the sural nerves. Eur Neurol . 2001; 45 241-248
34 Lewis R A, Sumner A J, Brown M J, Asbury A K. Multifocal demyelinating neuropathy with persistent conduction block. Neurology . 1982; 32 958-964
35 Thomas P K, Claus D, Jaspert A. et al . Focal upper limb demyelinating neuropathy. Brain . 1996; 119 765-774
36 Oh S J, Claussen G C, Odabasi Z, Palmer C P. Multifocal demyelinating motor neuropathy: pathologic evidence of inflammatory demyelinating polyradiculoneuropathy. Neurology . 1995; 45 1828-1832
37 Van den Berg-Vos M R, Van den Berg H L, Franssen H. et al . Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity?. Neurology . 2000; 54 26-32
38 Frohman E M, Tusa R, Mark A S, Cornblath D R. Vestibular dysfunction in chronic inflammatory demyelinating polyneuropathy. Ann Neurol . 1996; 39 529-535
39 Donaghy M, Earl C J. Ocular palsy preceding chronic relapsing polyneuropathy by several weeks. Ann Neurol . 1985; 17 49-50
40 Gupta V K. Ocular palsy and CIPD [comment; letter]. Neurology . 1996; 47 306
41 Dalakas M C, Teravainen H, Engel W K. Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies: incidence and management. Arch Neurol . 1984; 41 711-714
42 Sakakibara R, Hattori T, Kuwabara S, Yamanishi T, Yasuda K. Micturitional disturbance in patients with chronic inflammatory demyelinating polyneuropathy. Neurology . 1998; 50 1179-1182
43 Mendell J R, Kolkin S, Kissel J T, Weiss K L, Chakeres D W, Rammohan K W. Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology . 1987; 37 1291-1294
44 Thomas P K, Walker R W, Rudge P. et al . Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain . 1987; 110 53-76
45 Pakalnis A, Drake Jr E M, Barohn R J, Chakeres D W, Mendell J R. Evoked potentials in chronic inflammatory demyelinating polyneuropathy. Arch Neurol . 1988; 45 1014-1016
46 Uncini A, Gallucci M, Lugaresi A, Porrini A M, Onofrj M, Gambi D. CNS involvement in chronic inflammatory demyelinating polyneuropathy: an electrophysiological and MRI study. Electromyogr Clin Neurophysiol . 1991; 31 365-371
47 Feasby T E, Hahn A F, Koopman W J, Lee D H. Central lesions in chronic inflammatory demyelinating polyneuropathy: an MRI study. Neurology . 1990; 40 476-478
48 Naganuma M, Shima K, Matsumoto A, Tashiro K. Chronic multifocal demyelinating neuropathy associated with central nervous system demyelination. Muscle Nerve . 1991; 14 953-959
49 Crino P B, Grossman R I, Rostami A. Magnetic resonance imaging of the cauda equina in chronic inflammatory demyelinating polyneuropathy. Ann Neurol . 1993; 33 311-313
50 De Silva N R, Willison H J, Doyle D, Weir A I, Hadley D M, Thomas A M. Nerve root hypertrophy in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve . 1994; 17 168-170
51 Ginsberg L, Platts A D, Thomas P K. Chronic inflammatory demyelinating polyneuropathy mimicking a lumbar spinal stenosis syndrome. J Neurol Neurosurg Psychiatry . 1995; 59 189-191
52 Goldstein J M, Parks B J, Mayer P L, Kim J H, Sze G, Miller R G. Nerve root hypertrophy as the cause of lumbar stenosis in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve . 1996; 19 892-896
53 Mizuno K, Nagamatsu M, Hattori N. et al . Chronic inflammatory demyelinating polyradiculoneuropathy with diffuse and massive peripheral nerve hypertrophy: distinctive clinical and magnetic resonance imaging features. Muscle Nerve . 1998; 21 805-808
54 Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy. Neurology . 1991; 41 617-618
55 Uncini A, Di Muzio A, Sabatelli M, Magi S, Tonali P, Gambi D. Sensitivity and specificity of diagnostic criteria for conduction block in chronic inflammatory demyelinating polyneuropathy. Electroencephalogr Clin Neurophysiol . 1993; 89 161-169
56 Haq R U, Fries T J, Pendlebury W W, Kenny M J, Badger G J, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol . 2000; 57 1745-1750
57 Wilson J R, Park Y, Fisher M A. Electrodiagnostic criteria in CIDP: comparison with diabetic neuropathy. Electromyogr Clin Neurophysiol . 2000; 40 181-185
58 Nicolas G, Maisonobe T, Le Forestier N, Leger J M, Bouche P. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve . 2002; 25 26-30
59 Rotta F T, Sussman A T, Bradley W G, Ayyar D R, Sharma K R, Shebert R T. The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci . 2000; 173 129-139
60 Matsumuro K, Izumo S, Umehara F, Osame M. Chronic inflammatory demyelinating polyneuropathy: histological and immunopathological studies on biopsied sural nerves. J Neurol Sci . 1994; 127 170-178
61 Schmidt B, Toyka K V, Kiefer R, Full J, Hartung H P, Pollard J. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve . 1996; 19 474-487
62 Molenaar D S, Vermeulen M, de Haan R. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psych . 1998; 64 84-89
63 Bosboom W MJ, van den Berg H L, De Boer L. et al . The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy. Neurology . 1999; 53 837-845
64 Uncini A, De Angelis V M, Di Muzio A. et al . Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy. Clin Neurophysiol . 1999; 110 705-711
65 Gabriel C M, Howard R, Kinsella N. et al . Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry . 2000; 69 442-446
66 Hartung H-P, Toyka K V, Griffin J W. Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. In: Antel J, Birnbaum G, Hartung HP, eds. Neuroimmunology Cambridge: Blackwell Science 1998: 294-315
67 Yan W X, Taylor J, Andrias-Kauba S, Pollard J D. Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients. Ann Neurol . 2000; 47 765-775
68 Yan W X, Archelos J J, Hartung H P, Pollard J D. P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol . 2001; 50 286-292
69 Gabriel C M, Gregson N A, Hughes R AC. Anti-PMP22 antibodies in patients with inflammatory neuropathy. J Neuroimmunol . 2000; 104 139-146
70 Connolly A M, Pestronk A. Anti-tubulin autoantibodies in acquired demyelinating polyneuropathies. J Infect Dis . 1997; 176 S157-S159
71 Melendez-Vasquez C, Redford J, Choudhary P P. et al . Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol . 1997; 73 124-134
72 Ritz M F, Lechner-Scott J, Scott R J. et al . Characterization of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies. J Neuroimmunol . 2000; 104 155-163
73 van Schaik N I, Vermeulen M, van Doorn A P, Brand A. Anti-beta-tubulin antibodies have no diagnostic value in patients with chronic inflammatory demyelinating polyneuropathy. J Neurol . 1995; 242 599-603
74 Tagawa Y, Yuki N, Hirata K. The 301 to 314 amino acid residue of β-tubulin is not a target epitope for serum IgM antibodies in chronic inflammatory demyelinating polyneuropathy. J Neurol Sci . 1999; 163 44-46
75 Yuki N, Tagawa Y, Handa S. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol . 1996; 70 1-6
76 Ilyas A A, Mithen F A, Dalakas M C, Chen Z W, Cook S D. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci . 1992; 107 111-121
77 Simone I L, Annunziata P, Maimone D, Liguori M, Leante R, Livrea P. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci . 1993; 114 49-55
78 Oka N, Akiguchi I, Kawasaki T, Mizutani K, Satoi H, Kimura J. Tumor necrosis factor-α in peripheral nerve lesions. Acta Neuropathol . 1998; 95 57-62
79 Mathey E K, Pollard J D, Armati P J. TNF-α, INF-γ and IL-2 mRNA expression in CIDP sural nerve biopsies. J Neurol Sci . 1999; 163 47-52
80 Sharief M K, Ingram D A, Swash M, Thompson E J. IV immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barré syndrome. Neurology . 1999; 52 1833-1838
81 Dyck P J, O'Brien P C, Oviatt K F. et al . Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol . 1982; 11 136-141
82 Mehndiratta M M, Hughes R A. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev . 2002; 1 CD002062
83 Dyck P J, Daube J, O'Brien P. et al . Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med . 19896; 314 461-465
84 Hahn A F, Bolton C F, Pillay N. et al . Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy: a double-blind, sham-controlled, cross-over study. Brain . 1996; 119 1055-1066
85 Dyck P J, Litchy W J, Kratz K M. et al . A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol . 1994; 36 838-845
86 Vermeulen M, van Doorn A P, Brand A, Strengers P F, Jennekens F G, Busch H F. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry . 1993; 56 36-39
87 van Doorn A P, Brand A, Strengers P F, Meulstee J, Vermeulen M. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. Neurology . 1990; 40 209-212
88 Hahn A F, Bolton C F, Zochodne D, Feasby T E. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, cross-over study. Brain . 1996; 119 1067-1077
89 Mendell J R, Barohn R J, Freimer M L. et al . Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology . 2001; 56 445-449
90 Hughes R, Bensa S, Willison H. et al . Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol . 2001; 50 195-201
91 Dyck P J, O'Brien P, Swanson C, Low P, Daube J. Combined azathioprine and prednisone in chronic inflammatory-demyelinating polyneuropathy. Neurology . 1985; 35 1173-1176
92 Kolkin S, Nahman Jr S N, Mendell J R. Chronic nephrotoxicity complicating cyclosporine treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Neurology . 1987; 37 147-149
93 Hodgkinson S J, Pollard J D, McLeod J G. Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry . 1990; 53 327-330
94 Barnett M H, Pollard J D, Davies L, McLeod J G. Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve . 1998; 21 454-460
95 Good J L, Chehrenama M, Mayer R F, Koski C L. Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy. Neurology . 1998; 51 1735-1738
96 Brannagan T H, Pradhan A, Heiman-Patterson T. et al . High-dose cyclophosphamide without stem-cell rescue for refractory CIDP. Neurology . 2002; 58 1856-1858
97 Gorson K C, Allam G, Simovic D, Ropper A H. Improvement following interferon-alpha 2A in chronic inflammatory demyelinating polyneuropathy. Neurology . 1997; 48 777-780
98 Gorson K C, Ropper A H, Clark B D, Dew III B R, Simovic D, Allam G. Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-alpha 2a. Neurology . 1998; 50 84-87
99 Sabatelli M, Mignogna T, Lippi G. et al . Interferon-alpha may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry . 1995; 58 638-639
100 Choudhary P P, Thompson N, Hughes R A. Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol . 1995; 242 252-253
101 Martina I SJ, van Doorn A P, Schmitz P IM, Meulstee J, van der Meche G A F. Chronic motor neuropathies: response to interferon-b1a after failure of conventional therapies. J Neurol Neurosurg Psychiatry . 1999; 66 197-201
102 Rosenberg N L, Lacy J R, Kennaugh R C, Holers V M, Neville H E, Kotzin B L. Treatment of refractory chronic demyelinating polyneuropathy with lymphoid irradiation. Muscle Nerve . 1985; 8 223-232
103 Palace J, Newsom-Davis J, Lecky B. A randomized, double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group. Neurology . 1998; 50 1778-1783
104 Nagamatsu M, Terao S, Misu K. et al . Axonal and perikaryal involvement in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry . 1999; 66 727-734
105 Dawson-Hughes B, Harris S S, Krall E A, Dallas G E. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med . 1997; 337 670-676
106 Prince R L. Diet and the prevention of osteoporotic fractures. N Engl J Med . 1997; 337 701-702
107 Adachi J D, Bensen W G, Brown J. et al . Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med . 1997; 337 382-387
108 Libby P, Ganz P. Preventing glucocorticoid-induced osteoporosis. N Engl J Med . 1997; 337 420-421